MARK M SIECZKAREK Insider Trading $NBY NovaBay Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK M SIECZKAREK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK M SIECZKAREK. MARK M SIECZKAREK is President/CEO in CONCEPTUS INC ($CPTS) and Director in Wize Pharma, Inc. ($WIZP) and in NovaBay Pharmaceuticals, Inc. ($NBY) and CEO in NovaBay Pharmaceuticals, Inc. ($NBY) and Director in NovaBay Pharmaceuticals, Inc. ($NBY).
MARK M SIECZKAREK in NovaBay Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK M SIECZKAREK: Director
Holdings: 1,156,883 shares
Current Value: $4,569,688
Latest Transaction: Oct 28 2019
$NBY Market Capitalization: $61.37M
$NBY Previous Close: $3.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK M SIECZKAREK in NovaBay Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CPTS, WIZP, NBY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28 2019 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
| Aug 06 2019 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Grant | A | 0.00 | 167,938 | 0 | 1,156,883 | 988.9 K to 1.2 M (+16.98 %) | |
| Jun 06 2017 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 2.35 | 250,000 | 587,500 | 250,000 | |
| Jan 26 2017 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 3.60 | 238,609 | 858,992 | 936,857 | |
| Oct 03 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Buy | X | 1.91 | 273,447 | 522,284 | 988,945 | 715.5 K to 988.9 K (+38.22 %) |
| Aug 02 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 1.91 | 130,890 | 250,000 | 273,447 | |
| Aug 02 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Grant | A | 1.91 | 261,780 | 500,000 | 715,498 | 453.7 K to 715.5 K (+57.70 %) |
| Jun 08 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 2.78 | 675,000 | 1,876,500 | 698,248 | |
| May 13 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 1.91 | 130,890 | 250,000 | 142,557 | |
| May 13 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Grant | A | 1.91 | 261,780 | 500,000 | 453,718 | 191.9 K to 453.7 K (+136.39 %) |
| Mar 09 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.00 | 58,692 | 0 | 58,692 | |
| Feb 26 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Grant | A | 1.91 | 125,387 | 239,489 | 133,246 | 7.9 K to 133.2 K (+1,595.46 %) |
| Jan 06 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 2.02 | 16,032 | 32,385 | 23,246 | |
| Jun 16 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.79 | 24,128 | 19,061 | 180,362 | |
| Mar 05 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | P | 0.65 | 124,999 | 81,249 | 291,665 | |
| Mar 05 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | P | 0.60 | 166,666 | 100,000 | 291,665 | |
| Mar 05 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Buy | P | 0.60 | 166,666 | 100,000 | 196,466 | 29.8 K to 196.5 K (+559.28 %) |
Page: 1